19527 Investors following Lupin. Share this News with them.
0
Like this story, share it with millions of investors on M3
Lupin Q2 cons net profit up 46% at Rs 75.6 cr
Lupin has declared its second quarter numbers. Its consolidated net profit has jumped by 46% to Rs 75.6 crore for the quarter ended September 2007 as against Rs 51.8 crore. Net sales increased by 39.6% to Rs 675.6 crore from Rs 483.9 crore.
Lupin has declared its second quarter numbers. Its consolidated net profit has jumped by 46% to Rs 75.6 crore for the quarter ended September 2007 as against Rs 51.8 crore. Net sales increased by 39.6% to Rs 675.6 crore from Rs 483.9 crore.
Consolidated operating profit stood at Rs 131.4 crore versus Rs 71.5 crore. Operating profit margin improved to 19.4% from 14%.
Standalone net profit surged by 102% to Rs 118.08 crore from Rs 58.3 crore and net sales by 45% to Rs 714 crore from Rs 491.07 crore.
Standalone operating profit rose to Rs 141.2 crore from Rs 78.7 crore and operating profit margin improved to 19.7% from 16%.
Highlights
Lupin standalone numbers are bigger than consolidated number, because of inventory buildup for preparation of new launches to US in the winter season.
Driven by US market sales, finished dosage export revenue up 99%
API revenues up 20%
Domestic finished dosage revenues up 22% - EBITDA up 41% at Rs 1,314 million
Cefdinir market share at 14%, Price erosion not seen at the moment